Searched for
SUN PHARMA BOARD
SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....- Eicher Motors Q4 Results: Cons profit grows 12% YoY to Rs 1,520 crore, revenue jumps 16%Eicher Motors, the maker of Royal Enfield, posted a 12% rise in net profit for the March quarter of FY26. The company's revenue also saw a ...
- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...
- Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments BankBenchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to c...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Ram Shriram's Sherpalo Ventures to lead $60 million funding round in Skyroot; valuation hits $1.1 billionGIC, of Singapore, BlackRock, Greenko Group founders take part in round along with Sun Pharma founder Dilip Shanghvi family office as the 9...
- For investors with long-term perspective: 5 mid-cap stocks from different sectors with upside potential of up to 30%Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...
- Sun Pharma deal structurally strong, debt the only overhang: Amit KhuranaMarket expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma's acquisition is seen as strategically ...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Stocks in news: LIC, Maruti Suzuki, Sun Pharma, TCS, HULIndian markets extended their gains on Friday, with analysts predicting a steady recovery towards the 24,300-24,700 zone. Several prominent...
- Sun Pharma completes merger of TaroAs part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its...
- Sun Pharma to buy remaining 21.5% in Taro for Rs 2,892 crSun Pharma, India's largest drugmaker, is set to acquire the remaining 21.52% stake in Israel-based Taro Pharmaceutical Industries for ₹2,8...
- Sun Pharma names Aalok Shanghvi as whole-time directorSun Pharma Board has appointed Aalok Shanghvi as a whole-time director for a five-year term beginning June 1, 2023. Shanghvi, the son of Su...
- NCLT rejects Sun Pharma’s plan to demerge overseas subsidiaryThe company had approached the Ahmedabad bench of NCLT for an approval to transfer investment undertakings from Sun Pharma to its Netherlan...
- Taro appoints Sun Pharma CFO Uday Baldota its CEOBaldota, who has also been nominated to Taro's board of directors, is expected to begin his role as CEO on or about April 1, 2017, and will...
- Taro postpones shareholders meeting on merger with Sun PharmaIsraeli firm Taro Pharmaceutical Industries Ltd said it postponed a meeting of shareholders to consider the company's proposed merger with ...
- Taro Pharma panel turns down Sun Pharma's open offer priceSun Pharma, which holds about 67% stake in Taro, had made an open offer of $24.50 a share last year for the remaining stake.
- Sun Pharma says won't revise taro offer priceMumbai-based Sun Pharma will not revise its offer price to minority shareholders of Isreali drug maker Taro pharma, a company official said.
- Sun Pharma asks Taro board to stop supporting LevittSun Pharma has written to the board of Taro to stop supporting the Levitt family who has been opposing the acquisition of the company by th...
Load More
